248 related articles for article (PubMed ID: 33894051)
1. Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
Just MA; Van Mater D; Wagner LM
Pediatr Blood Cancer; 2021 Aug; 68(8):e29084. PubMed ID: 33894051
[TBL] [Abstract][Full Text] [Related]
2. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano A; Mir O; Mathoulin-Pelissier S; Penel N; Piperno-Neumann S; Bompas E; Chevreau C; Duffaud F; Entz-Werlé N; Saada E; Ray-Coquard I; Lervat C; Gaspar N; Marec-Berard P; Pacquement H; Wright J; Toulmonde M; Bessede A; Crombe A; Kind M; Bellera C; Blay JY
Lancet Oncol; 2020 Mar; 21(3):446-455. PubMed ID: 32078813
[TBL] [Abstract][Full Text] [Related]
3. Cabozantinib as an emerging treatment for sarcoma.
Schöffski P; Blay JY; Ray-Coquard I
Curr Opin Oncol; 2020 Jul; 32(4):321-331. PubMed ID: 32541320
[TBL] [Abstract][Full Text] [Related]
4. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
5. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.
Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT
Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852
[TBL] [Abstract][Full Text] [Related]
6. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
Schuetze SM
J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Anderson PM; Bielack SS; Gorlick RG; Skubitz K; Daw NC; Herzog CE; Monge OR; Lassaletta A; Boldrini E; Pápai Z; Rubino J; Pathiraja K; Hille DA; Ayers M; Yao SL; Nebozhyn M; Lu B; Mauro D
Pediatr Blood Cancer; 2016 Oct; 63(10):1761-70. PubMed ID: 27362300
[TBL] [Abstract][Full Text] [Related]
9. [Pre- and postoperative chemotherapy in bone and soft tissue tumors].
Höffken K
Langenbecks Arch Chir; 1987; 372():311-4. PubMed ID: 3481009
[TBL] [Abstract][Full Text] [Related]
10. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy for osteosarcoma and Ewing sarcoma.
Meyers PA
Am Soc Clin Oncol Educ Book; 2015; ():e644-7. PubMed ID: 25993235
[TBL] [Abstract][Full Text] [Related]
12. Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.
Rivera-Valentin RK; Zhu L; Hughes DP
Paediatr Drugs; 2015 Aug; 17(4):257-71. PubMed ID: 26002157
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapeutic concepts for bone sarcomas].
Kager L; Bielack S
Unfallchirurg; 2014 Jun; 117(6):517-22. PubMed ID: 24903502
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the management of bone tumors--1996.
Craft AW
Ann N Y Acad Sci; 1997 Sep; 824():167-79. PubMed ID: 9382441
[No Abstract] [Full Text] [Related]
15. Standard chemotherapy for malignant bony tumors in children and young adults.
Rafique A; Kent PM
Curr Probl Cancer; 2013; 37(4):207-14. PubMed ID: 24238586
[No Abstract] [Full Text] [Related]
16. [Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
Guo W; Tang XD; Tang S; Yang Y
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(12):805-8. PubMed ID: 16889724
[TBL] [Abstract][Full Text] [Related]
17. Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Reed DR; Grohar P; Rubin E; Binitie O; Krailo M; Davis J; DuBois SG; Janeway KA
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30583. PubMed ID: 37501549
[TBL] [Abstract][Full Text] [Related]
18. Advances in the Treatment of Pediatric Bone Sarcomas.
Grohar PJ; Janeway KA; Mase LD; Schiffman JD
Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for Bone Sarcoma in Adults.
Wagner MJ; Livingston JA; Patel SR; Benjamin RS
J Oncol Pract; 2016 Mar; 12(3):208-16. PubMed ID: 26962160
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
Bond M; Bernstein ML; Pappo A; Schultz KR; Krailo M; Blaney SM; Adamson PC
Pediatr Blood Cancer; 2008 Feb; 50(2):254-8. PubMed ID: 17262795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
